KLAS Research is healthcare IT’s most trusted independent evaluator, capturing candid insights from thousands of provider organizations every year. Their rigorous methodology ensures that vendor scores reflect real customer experiences — not marketing claims.
In 2025, KLAS published its inaugural First Look Report on NextPatient, interviewing 17 organizations across NextPatient’s entire eligible customer base. The findings were clear: NextPatient customers are among the most satisfied in the patient self-scheduling market.
Then in the 2026 Best in KLAS Awards — the industry’s most recognized annual benchmark — NextPatient scored 91.8 out of 100 in patient self-scheduling, outscoring every other rated vendor in the category including Relatient Dash Schedule (89.4) and DexCare (88.7).
These aren’t marketing testimonials. They’re candid, independently gathered responses from KLAS Research’s confidential customer interviews.
KLAS asked customers about the specific outcomes they expected when purchasing NextPatient. Here’s what they found:
| Efficient online scheduling |  |
| Improved online presence | |
| Reduced no-show rates | |
| Paid patient account balances | |
| Simplified digital check-in | |
In the 2026 Best in KLAS report, NextPatient was the only fully-rated solution in the patient self-scheduling segment — and outperformed every other vendor evaluated.
| Vendor | Score | Orgs | Data status |
|
91.8 | 24 | Fully rated |
| Relatient Dash Schedule | 89.4* | 8 | Limited data* |
| DexCare | 88.7* | 6 | Limited data* |
Exceptional service
Rated A+ for phone/web support and executive involvement. KLAS customers describe the service as “nothing short of fantastic.”
Seamless EHR integration
Deep integrations with athenahealth, ModMed, Nextech, NextGen, and more. Unlike competitors like Klara, Luma Health, and Solutionreach, NextPatient was built scheduling-first.
Real ROI, fast
88% of customers saw outcomes immediately. Rated A+ for money’s worth — and 100% say NextPatient avoids nickel-and-diming.
